Products

Anti-hyperlipidemic

Save Tablets (Atorvastatin)

Save, a HMG-CoA reductase inhibitor, is a lipid lowering agent indicated to reduce the risk of MI, stroke, revascularization procedures, and angina in patients without CHD, but with multiple risk factors, reduces the risk of MI and stroke in patients with type 2 diabetes without CHD, but with multiple risk factors, reduces the risk of non-fatal MI, fatal and non-fatal stroke, revascularization procedures, hospitalization for CHF, and angina in patients with CHD, reduces elevated total-C, LDL-C, apo B, and TG levels and increase HDL-C in adult patients with primary hyperlipidemia (heterozygous familial and nonfamilial) and mixed dyslipidemia, reduces elevated TG in patients with hypertriglyceridemia and primary dysbetalipoproteinemia, reduces total-C and LDL-C in patients with homozygous familial hypercholesterolemia and reduces elevated total-C, LDL-C, and apo B levels in boys and postmenarchal girls, 10 to 17 years of age, with heterozygous familial hypercholesterolemia after failing an adequate trial of diet therapy.

Sitemap | Contact Us Copyright © 2017 Wilson's Pharmaceuticals. All Rights Reserved.